慢性肾脏病孕妇的不良妊娠结局:系统综述与荟萃分析
该系统综述与荟萃分析纳入19项研究共3 251 902名女性,量化慢性肾脏病(CKD)与不良妊娠结局的关联。采用随机效应模型,发现以eGFR或血清肌酐定义CKD时效应量更大但置信区间更宽;CKD 3-5期较1-2期子痫前期、早产和新生儿重症监护入院风险更高但估计不精确;糖尿病肾脏病者母亲死亡、小于胎龄儿、子痫前期和妊娠期高血压风险更高。
要点
- CKD 3-5期较1-2期子痫前期OR 55.18(95%CI 2.63-1157.68)vs OR 24.74(95%CI 1.75-348.70)。
- CKD 3-5期较1-2期早产OR 20.24(95%CI 2.85-143.75)vs OR 8.18(95%CI 1.54-43.46)。
- CKD 3-5期较1-2期新生儿重症监护入院OR 19.32(95%CI 3.07-121.68)vs OR 9.77(95%CI 2.49-38.39)。
核心结论
- 妊娠期CKD定义存在异质性,未来研究应考虑标准化其定义和测量。
研究设计与样本
- 系统检索EMBASE和MEDLINE从建库至2023年1月5日,纳入英文随机对照试验、队列研究和病例对照研究。
- 共纳入19项研究,3 251 902名女性,两名评价者独立提取数据,采用随机效应模型估计风险。
主要发现
- 以eGFR或血清肌酐定义CKD产生效应量更大但置信区间更宽的结果。
- CKD 3-5期较1-2期子痫前期OR 55.18(95%CI 2.63-1157.68)vs OR 24.74(95%CI 1.75-348.70)。
- CKD 3-5期较1-2期早产OR 20.24(95%CI 2.85-143.75)vs OR 8.18(95%CI 1.54-43.46)。
- CKD 3-5期较1-2期新生儿重症监护入院OR 19.32(95%CI 3.07-121.68)vs OR 9.77(95%CI 2.49-38.39)。
- 糖尿病肾脏病者较无糖尿病肾脏病者母亲死亡、小于胎龄儿、子痫前期和妊娠期高血压风险更高。
局限性
- 妊娠期CKD定义存在异质性。
- 未来研究应考虑标准化妊娠期CKD的定义和测量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic kidney disease (CKD) is associated with an increased risk of adverse pregnancy outcomes, but the risk at different stages of CKD (defined by estimated glomerular filtration rate, eGFR) compared with women without CKD has not been quantified in large cohorts. OBJECTIVES: To quantify the association between CKD and adverse pregnancy outcomes according to CKD definition, CKD stage and presence or absence of diabetes. SEARCH STRATEGY: A systematic search of EMBASE and MEDLINE from inception to 5 January 2023. SELECTION CRITERIA: English-language randomised controlled trials as well as cohort and case-control studies investigating adverse pregnancy outcomes in pregnant women with CKD. DATA COLLECTION AND ANALYSIS: Two reviewers conducted independent data extractions. A random-effects model was used to estimate risk. MAIN RESULTS: We included 19 studies with 3 251 902 women. Defining CKD using eGFR or serum creatinine produced results with greater effect size but wider confidence intervals. Compared with CKD stages 1-2, women with CKD stages 3-5 have a greater risk, but also greater imprecision in the risk estimate, of the following outcomes: pre-eclampsia (OR 55.18, 95% CI 2.63-1157.68, vs OR 24.74, 95% CI 1.75-348.70), preterm birth (OR 20.24, 95% CI 2.85-143.75, vs OR 8.18, 95% CI 1.54-43.46) and neonatal intensive care unit admission (OR 19.32, 95% CI 3.07-121.68, vs OR 9.77, 95% CI 2.49-38.39). Women with diabetic kidney disease, compared with women without diabetic kidney disease, have higher risks of maternal mortality, small-for-gestational-age neonates, pre-eclampsia and gestational hypertension. CONCLUSIONS: There is heterogeneity in the definition of CKD in pregnancy. Future studies should consider ways to standardise its definition and measurement in pregnancy.
引用
- Jeyaraman D, Walters B, Bramham K, et al. Adverse pregnancy outcomes in pregnant women with chronic kidney disease: A systematic review and meta-analysis. BJOG. 2024. PMID: 38488268. doi:10.1111/1471-0528.17807
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。